Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 02, 2015 9:53 PM ET

Pharmaceuticals

Company Overview of Formula Pharmaceuticals, Inc.

Company Overview

Formula Pharmaceuticals, Inc. develops novel therapeutics that target cancer stem cells and various minimal residual diseases. It offers FPI-01, a multi-peptide immunotherapeutic product candidate in clinical development for the maintenance of first-remission in acute myeloid leukemia, mesothelioma, and other cancers. The company was founded in 2009 and is based in Berwyn, Pennsylvania.

1055 Westlakes Drive

Suite 300

Berwyn, PA 19312

United States

Founded in 2009

Phone:

610-727-4172

Fax:

610-896-3546

Key Executives for Formula Pharmaceuticals, Inc.

Founder, Chairman and Chief Executive Officer
Co-Founder, President, Chief Business Officer and Director
Age: 52
Senior Vice President of Finance and Treasurer
Senior Vice President of Clinical Development
Age: 53
General Counsel and Secretary
Age: 50
Compensation as of Fiscal Year 2014.

Formula Pharmaceuticals, Inc. Key Developments

Formula Pharmaceuticals, Inc. Presents at Life Sciences Summit 2014, Oct-29-2014 02:15 PM

Formula Pharmaceuticals, Inc. Presents at Life Sciences Summit 2014, Oct-29-2014 02:15 PM. Venue: 10 on the Park at Time Warner Center, 60 Columbus Circle, 10th Floor, New York, NY 10019, United States.

Formula Pharmaceuticals Appoints Dr. Daniel D. Von Hoff as Chairman of the Scientific Advisory Board

Formula Pharmaceuticals, Inc. announced the appointment of Daniel D. Von Hoff, MD, FACP, as Chairman of the company's Scientific Advisory Board. Dr. Von Hoff is currently Physician in Chief, Distinguished Professor and Director of Clinical Translational Research Division at TGen (Translational Genomics Research Institute), Phoenix, AZ. He is also Chief Scientific Officer for US Oncology and for Scottsdale Healthcare's Clinical Research Institute and holds an appointment as Professor of Medicine, Mayo Clinic, Scottsdale, AZ. Dr. Von Hoff served on the National Cancer Advisory Board from 2004-2010.

Similar Private Companies By Industry

Company Name Region
Essential Resources, Inc. United States
ThoRx Laboratories, Inc. United States
Redox Pharmaceutical Corporation United States
14605 Incorporated United States
LaneLabs USA, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 11, 2015
Allogeneic, Non-Viral Chimeric Antigen Receptor Technology Platform
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Formula Pharmaceuticals, Inc., please visit www.formulapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.